• 14 - HCT Across MDS Genetic Subtypes, Part I: Expanding Access to Older Patients

  • Jan 14 2025
  • Length: 32 mins
  • Podcast

View show details

  • Summary

  • In this two-part "Explore Cell Therapy" podcast episode, Coleman Lindsley, MD, PhD, and Corey Cutler, MD, MPH, FRCP(C), discuss recent and evolving research supporting the broad benefits of hematopoietic cell transplant (HCT) across all genetic subtypes of myelodysplastic syndrome (MDS), including for patients with high-risk mutations like TP53.

    In Part I: Expanding Access to Older Patients, guests explore major advances in transplant for older patients with MDS, highlighting the recent expansion of coverage through the Centers for Medicare and Medicaid Services (CMS), a significant milestone driven by recent studies that demonstrate the safety and efficacy of HCT in patients over 65 years old.

    To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

    Show more Show less
Show more Show less

What listeners say about 14 - HCT Across MDS Genetic Subtypes, Part I: Expanding Access to Older Patients

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available